Simple nerve block could prevent Post-Surgery heart rhythm problems

NCT ID NCT05932485

Completed Disease control Sponsor: Yangzhou University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a stellate ganglion block (a nerve injection) before coronary artery bypass surgery can prevent new atrial fibrillation, a common complication. 108 patients were included. The approach aims to calm the nervous system and reduce inflammation. Results could lead to a simple way to lower stroke and heart failure risks after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: stellate ganglion block with ropivacaine
What this could lead to: If it works, this could offer a simple procedure to lower the risk of atrial fibrillation after heart bypass surgery, reducing stroke and other complications.
What could go wrong: This is a small, single-center study with 108 patients. The nerve block may not work for everyone, and there are risks like bleeding or nerve damage from the injection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder atrial fibrillation prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

STELLATE GANGLION BLOCK

Contacts and locations

Locations

the Affiliated Hospital of Yangzhou University, Yangzhou University

Yangzhou, Jiangsu, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.